Stryker receives US FDA Pre-market approval for the Surpass Streamline™ Flow Diverter to treat large and giant unruptured aneurysms
17 July 2018
Stryker Corporation announced today that the U.S. Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline Flow Diverter to treat unruptured large and giant wid
